Table 1 Clinical characteristics of the study population
IC, N = 30 | TUC, N = 22 | P | |
|---|---|---|---|
Mean ± SD age, years | 60.5 ± 8.9 | 59.0 ± 9.2 | 0.551 |
Gender, n (%) | 0.393 | ||
Male | 27 (90) | 18 (81.8) | |
Female | 3 (10) | 4 (18.2) | |
Pathological finding, n (%) | 0.402 | ||
Urothelial cell carcinoma | 23 (76.7) | 20 (90.9) | |
Squamous cell carcinoma | 4 (13.3) | 1 (4.5) | |
Adenocarcinoma | 3 (10) | 1 (4.5) | |
Staging, n (%) | 0.167 | ||
Organ-confined disease (≤ pT2, pN0) | 20 (66.7) | 8 (36.4) | |
Extravesical disease (> pT2 or > pN0) | 7 (23.3) | 13 (59) | |
Metastatic disease | 3 (10) | 1 (4.5) | |
Comorbidity, n (%) | |||
Cardiovascular disease | 12 (40) | 8 (36.4) | 0.790 |
Diabetes mellitus | 6 (20) | 3 (13.6) | 0.717 |
Renal insufficiency | 7 (23.3) | 10 (45.4) | 0.093 |
Anemia | 21 (70) | 14 (63.6) | 0.629 |
Hypoalbuminemia | 6 (20) | 8 (36.4) | 0.189 |
Body mass index | |||
Underweight | 24 (80) | 15 (68.2) | 0.389 |
Norm weight | 6 (20) | 6 (27.3) | |
Overweight | 0 | 1 (4.5) | |
ASA score, n (%) | 0.830 | ||
2 | 21 (70) | 16 (72.7) | |
3 | 9 (30) | 6 (27.3) | |